U.S. researchers said they were able to prevent abdominal aortic aneurysms in mice genetically susceptible to the fatal condition by removing angiotensin II, a hormone that produces the cyclophilin A protein associated with aneurysm development. They are searching for treatments that could target the same protein in humans.

Full Story:

Related Summaries